DAXOR CORPORATION

Insiders Daxor Corporation

Equities

DXR

US2394671034

End-of-day quote Nasdaq Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
9.59 ^USD	+2.46%		+5.27%	-0.10%

06-05	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI
04-16	Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	06-05	CI
Daxor Corporation Appoints Caleb Desrosiers, JD, MPA to its Board of Directors	21/01/22	CI
Daxor Corp. Approves Annual Dividend, Payable on December 29, 2016; Names Michael Feldschuh as President and Chief Executive Officer on Permanent Basis	18/11/16	CI
Daxor Corporation Announces Executive Changes	23/09/16	CI
Daxor Corp. Appoints Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis; Declares Increase in Dividend for 2015, Payable on December 29, 2015	10/12/15	CI
Daxor Corporation Appoints Lisa Quartley as its First SVP, Marketing and Commercial Development	02/09/15	CI
Daxor Corp Appoints Michael Feldschuh as Executive Vice President	18/12/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer